Central Venous Catheterization in Children: Jugulo-subclavian Venous Confluence Versus Internal J… (NCT07459088) | Clinical Trial Compass
CompletedNot Applicable
Central Venous Catheterization in Children: Jugulo-subclavian Venous Confluence Versus Internal Jugular Vein
Tunisia88 participantsStarted 2023-12-17
Plain-language summary
The goal of this study was to compare ultrasound-guided central venous catheterization via the IJV to the JSVC using the supraclavicular approach in children. The main questions it aims to answer are:
1. Are ultrasound-guided central venous catheterization via the internal jugular vein (IJV) and via the jugular-supraclavicular vein (JSVC) using the supraclavicular approach equivalent in terms of procedural efficacy (e.g., success rate, time to cannulation) in children?
2. Are these two techniques comparable in terms of safety (e.g., complication rates, adverse events) in pediatric patients?
Who can participate
Age range
1 Month – 14 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Children aged 1 month to 14 years, admitted to the pediatric intensive care unit of the anesthesiology and critical care department at Béchir Hamza Children's Hospital in Tunis, or scheduled for major elective surgery under general anesthesia requiring central venous catheter placement.
Exclusion Criteria:
* Patients in whom ultrasound revealed a thrombotic formation in the vein.
* Patients for whom the vein could not be adequately visualized on ultrasound
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
first-attempt Success rate
Timeframe: From the day of randomization until radiographic confirmation of central venous catheter position, assessed up to 6 hours.